Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PAI for pain after TKA with ACB and IPACK
NCT04749615Phase 4Completed
- Sponsor
- Hospital for Special Surgery
- Start
- Dec 2020
- Primary completion
- Apr 2022
- Modality
- Reversible Covalent Inhibitors, Recombinant Proteins and Enzymes, Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 4 trial of bupivacaine, epinephrine, morphine, methylprednisolone, cefazolin in postoperative pain, sponsored by Hospital for Special Surgery. Started Dec 2020; status: completed.
02
Drugs
bupivacaineepinephrinemorphinemethylprednisolonecefazolin
03
Conditions
postoperative pain
Beyond the preview
Go deeper on NCT04749615.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04749615.